BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19538493)

  • 1. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee.
    Ison MG; Hager J; Blumberg E; Burdick J; Carney K; Cutler J; Dimaio JM; Hasz R; Kuehnert MJ; Ortiz-Rios E; Teperman L; Nalesnik M
    Am J Transplant; 2009 Aug; 9(8):1929-35. PubMed ID: 19538493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.
    Green M; Covington S; Taranto S; Wolfe C; Bell W; Biggins SW; Conti D; DeStefano GD; Dominguez E; Ennis D; Gross T; Klassen-Fischer M; Kotton C; LaPointe-Rudow D; Law Y; Ludrosky K; Menegus M; Morris MI; Nalesnik MA; Pavlakis M; Pruett T; Sifri C; Kaul D
    Transplantation; 2015 Feb; 99(2):282-7. PubMed ID: 25594557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatrics and donor-derived disease transmission: The US OPTN experience.
    Green M; Covington S; Taranto S; Michaels MG; Wolfe C; Kaul DR
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29341396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on donor-derived disease transmission in organ transplantation.
    Ison MG; Nalesnik MA
    Am J Transplant; 2011 Jun; 11(6):1123-30. PubMed ID: 21443676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee.
    Penumarthi LR; La Hoz RM; Wolfe CR; Jackson BR; Mehta AK; Malinis M; Danziger-Isakov L; Strasfeld L; Florescu DF; Vece G; Basavaraju SV; Michaels MG
    Am J Transplant; 2021 May; 21(5):1911-1923. PubMed ID: 33290629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee.
    Kusne S; Taranto S; Covington S; Kaul DR; Blumberg EA; Wolfe C; Green M
    Am J Transplant; 2016 Dec; 16(12):3562-3567. PubMed ID: 27376472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years of donor-derived disease: A report of the disease transmission advisory committee.
    Kaul DR; Vece G; Blumberg E; La Hoz RM; Ison MG; Green M; Pruett T; Nalesnik MA; Tlusty SM; Wilk AR; Wolfe CR; Michaels MG
    Am J Transplant; 2021 Feb; 21(2):689-702. PubMed ID: 32627325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018.
    Malinis M; La Hoz RM; Vece G; Annambhotla P; Aslam S; Basavaraju SV; Bucio J; Danziger-Isakov L; Florescu DF; Jones JM; Rana M; Wolfe CR; Michaels MG
    Transpl Infect Dis; 2022 Apr; 24(2):e13800. PubMed ID: 35064737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication gaps associated with donor-derived infections.
    Miller R; Covington S; Taranto S; Carrico R; Ehsan A; Friedman B; Green M; Ison MG; Kaul D; Kubak B; Lebovitz DJ; Lyon GM; Nalesnik MA; Pruett TL; Teperman L; Vasudev B; Blumberg E
    Am J Transplant; 2015 Jan; 15(1):259-64. PubMed ID: 25376342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.
    Theodoropoulos NM; La Hoz RM; Wolfe C; Vece G; Bag R; Berry GJ; Bucio J; Danziger-Isakov L; Florescu DF; Goldberg D; Ho CS; Lilly K; Malinis M; Mehta AK; Nalesnik MA; Sawyer R; Strasfeld L; Wood RP; Michaels MG
    Transpl Infect Dis; 2021 Feb; 23(1):e13458. PubMed ID: 32894634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid organ transplant donors with central nervous system infection.
    Kaul DR; Covington S; Taranto S; Green M; Lyon GM; Kusne S; Miller RA; Blumberg EA
    Transplantation; 2014 Sep; 98(6):666-70. PubMed ID: 24914569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
    Goldman JD; Pouch SM; Woolley AE; Booker SE; Jett CT; Fox C; Berry GJ; Dunn KE; Ho CS; Kittleson M; Lee DH; Levine DJ; Marboe CC; Marklin G; Razonable RR; Taimur S; Te HS; Anesi JA; Fisher CE; Sellers MT; Trindade AJ; Wood RP; Zaffiri L; Levi ME; Klassen D; Michaels MG; La Hoz RM; Danziger-Isakov L
    Transpl Infect Dis; 2023 Feb; 25(1):e14013. PubMed ID: 36694448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation.
    Garzoni C; Ison MG
    Transplantation; 2011 Dec; 92(12):1297-300. PubMed ID: 21996654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived infections in solid organ transplant patients: toward a holistic approach.
    Benamu E; Wolfe CR; Montoya JG
    Curr Opin Infect Dis; 2017 Aug; 30(4):329-339. PubMed ID: 28538045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigilance Data in Organ Donation and Solid Organ Transplantation in Germany: Six Years of Experience 2016-2022.
    Böhler K; Rahmel A; Barreiros AP
    Transpl Int; 2023; 36():11610. PubMed ID: 37745644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the OPTN transmissible diseases policy and US PHS increased risk donor guidelines on living donor candidates.
    Hays R; Gordon EJ; Ison MG; LaPointe Rudow D
    Am J Transplant; 2019 Dec; 19(12):3233-3239. PubMed ID: 31338956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
    Nalesnik MA; Woodle ES; Dimaio JM; Vasudev B; Teperman LW; Covington S; Taranto S; Gockerman JP; Shapiro R; Sharma V; Swinnen LJ; Yoshida A; Ison MG
    Am J Transplant; 2011 Jun; 11(6):1140-7. PubMed ID: 21645251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee.
    Kaul DR; Tlusty SM; Michaels MG; Limaye AP; Wolfe CR
    Clin Transplant; 2018 Oct; 32(10):e13370. PubMed ID: 30080289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.
    Len O; Garzoni C; Lumbreras C; Molina I; Meije Y; Pahissa A; Grossi P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():10-8. PubMed ID: 24476053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor transmitted malignancies.
    Buell JF; Beebe TM; Trofe J; Gross TG; Alloway RR; Hanaway MJ; Woodle ES
    Ann Transplant; 2004; 9(1):53-6. PubMed ID: 15478892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.